Intellia Therapeutics News

Intellia Therapeutics | DEFA14A: Others

Apr 30 04:58

Intellia Therapeutics | ARS: Annual Report to Security Holders

Apr 30 04:38

Intellia Therapeutics | DEF 14A: Definitive information statements

Apr 30 04:20

Intellia Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Dube Michael P

Apr 23 04:13

Intellia Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 17 04:18

Intellia Therapeutics | 8-K: Current report

Apr 16 04:26

Intellia Therapeutics | 8-K: Current report

Mar 22 21:27

Intellia Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Sepp-Lorenzino Laura

Mar 6 05:17

Intellia Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer BASTA JAMES

Mar 6 05:17

Intellia Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hicks Derek

Mar 6 05:16

Intellia Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Clark Eliana

Mar 6 05:16

Intellia Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Goddard Glenn

Mar 6 05:15

Intellia Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lebwohl David

Mar 6 05:15

Intellia Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LEONARD JOHN M

Mar 6 05:15

Intellia Therapeutics | 424B5: Prospectus

Feb 26 20:05

Intellia Therapeutics | 424B5: Prospectus

Feb 24 11:28

Intellia Therapeutics | 8-K: Current report

Feb 24 06:21

Intellia Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Feb 23 05:20

Intellia Therapeutics | 10-K: Annual report

Feb 23 05:07

Intellia Therapeutics | 8-K: Intellia Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Company Progress

Feb 22 20:46